decisionhealth Newsletters, Answer Books - 2006 Issue 4 (April)
Appendix E - National Coverage Determinations Manual / NCD 406
Subscribe or sign in to view the full article.
Article Overview
This article summarizes selected National Coverage Determinations Manual entries and focuses on CMS coverage policy for CA 125 tumor antigen testing. It is useful for coding, billing, and compliance professionals who need to understand the scope of Medicare coverage guidance, including when the service is addressed, the general clinical contexts discussed, and the limitations noted in the policy.
Why This Topic Matters
National coverage determinations affect whether a service is payable under Medicare and how related laboratory or procedure claims are interpreted. This page helps readers identify the relevant CMS policy topic, the affected specialty area, and the general boundaries of the coverage discussion without relying on the premium text.
Article Sections
-
20.25 Cardiac Catheterization Performed in Other Than a Hospital Setting
A short policy item noting a coverage status change for a cardiac catheterization setting issue and its effective date information.
-
190.28 Tumor Antigen by Immunoassay – CA 125
The main policy section addressing CMS coverage guidance for CA 125 tumor marker testing, including the clinical contexts and limitations discussed in the manual entry.
-
Indications
General circumstances under which CA 125 testing is discussed in the policy, including broad oncology-related uses and monitoring contexts.
-
Limitations
The boundaries of the coverage discussion, including situations the policy says are not covered and the overall scope of use described by CMS.
What You Will Learn
- What CMS policy topics are covered in this NCD manual excerpt
- How the article frames CA 125 within Medicare coverage guidance
- Which general clinical contexts are associated with the laboratory policy
- What coverage limitations are discussed at a high level
- What effective date and review information is included in the entry
Who Should Read This
- Medical coders
- Billing specialists
- Compliance staff
- Revenue cycle professionals
- Healthcare administrators
- Laboratory billing personnel
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com